USE OF COMBINED DRUG TRAVOCORT IN PATIENTS WITH INFLAMMATORY DISEASE OF EXTERNAL EAR
Prevention and treatment of patients with inflammatory diseases of external ear remains a challenge despite a large number of ways and methods of the disease treatment. External otitis is a common case in otolaryngologist's practice. According to some sources, the prevalence of the disease is 17 to 23% of the entire ear pathology [1, 9]; the rates are much higher in case of a combined outer and middle ear inflammation [11]. Lately there has been an increase in the incidence of otitis externa which is explained by a number of reasons. The key reasons are worsening of the environmental condition, increase of resistance of infectious agents, increase in the number of patients with poor immune status, growth of endocrine and other chronic diseases.